FENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHY

Authors

  • Parpibaeva Dinara Ayupovna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Salayeva Muborak Saidabdullayevna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Salimova Nargiza Djurabaevna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Ergashov Nodirbek Shermuxamat o’g’li Tashkent Medical Academy, Tashkent, Uzbekistan
  • Buvamuxamedova Nasiba Taxirovna Tashkent Medical Academy, Tashkent, Uzbekistan

Keywords:

- Diabetes mellitus, Diabetic retinopathy, Dyslipidemia, Fenofibrate (Tricor).

Abstract

Today, diabetes mellitus is considered a “pandemic”, and the number of patients with this disease and its complications is increasing day by day. Diabetes mellitus is a severe complication of diabetic retinopathy that leads to blindness and disability in people. Timely detection, prevention and effective treatment of this complication are among the urgent tasks facing endocrinologists. Today, taking into account such risk factors as hyperglycemia, dyslipidemia and uncontrolled arterial hypertension, which play a leading role in the pathogenesis of complications of diabetic retinopathy, many studies are being carried out in the world on the effective complex treatment of this complication. This article talks about the next study conducted at the multidisciplinary clinic of the Tashkent Medical Academy.

Downloads

Published

2023-05-08

Issue

Vol. 15 (2023)

Section

Articles

How to Cite

FENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHY. (2023). Spectrum Journal of Innovation, Reforms and Development, 15, 1-8. https://sjird.journalspark.org/index.php/sjird/article/view/634

Most read articles by the same author(s)